Blood coagulation in hemophilia A and hemophilia C

Blood

Volumn 91, Issue 12, 1998, Pages 4581-4592

  Cawthern, Kevin M ^a   Van't Veer, Cornelis ^a   Lock, Jennifer B ^a   DiLorenzo, Maria E ^a   Branda, Richard F ^a   Mann, Kenneth G ^a  

^a UNIVERSITY OF VERMONT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 5; FIBRINOPEPTIDE A; OSTEONECTIN; RECOMBINANT BLOOD CLOTTING FACTOR 8; THROMBIN; THROMBIN ANTITHROMBIN COMPLEX; THROMBOPLASTIN;

ADULT; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING FACTOR 11 DEFICIENCY; CLINICAL ARTICLE; FEMALE; HEMOPHILIA A; HUMAN; MALE; PRIORITY JOURNAL; THROMBIN TIME; THROMBOCYTE ACTIVATION;

EID: 2642651894     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.12.4581.412k12_4581_4592     Document Type: Article

References (61)

1. Davie EW, Fujikawa K, Kisiel W: The coagulation cascade: Initiation, maintenance and regulation. Biochemistry 30:10363, 1991
2. Rapaport SI, Rao LVM: The tissue factor pathway: How it has become a 'prima ballerina.' Thromb Haemost 74:7, 1995
3. Mann KG, Nesheim ME, Church WR, Haley P, Krishnaswamy S: Surface-dependent reactions of the vitamin K-dependent enzyme complexes. Blood 76:1, 1990
4. Mann KG, Krishnaswamy S, Lawson JH: Surface-dependent hemostasis. Seinin Hematol 29:213, 1992
5. Morrissey JH, Macik BG, Neuenschwander PF, Comp PC: Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation. Blood 81:734, 1993
6. Osterud B, Rapaport SI: Activation of factor IX by the reaction product of tissue factor and factor VII: Additional pathway for initiating blood coagulation. Proc Natl Acad Sci USA 74:5260, 1977
7. Morrison SA. Jesty J: Tissue factor-dependent activation of tritium-labeled factor IX and factor X in human plasma. Blood 63:1338, 1984
8. Lawson JH, Kalafatis M, Stram S, Mann KG: A model for the tissue factor pathway to thrombin. I. An empirical study. J Biol Chem 269:23357, 1994
9. Jones KC, Mann KG: A model for the tissue factor pathway to thrombin. II. A mathematical simulation. J Biol Chem 269:23367, 1994
10. Nesheim ME, Taswell JB, Mann KG: The contribution of bovine factor V and factor Va to the activity of prothrombinase. J Biol Chem 254:10952, 1979
11. Pieters J, Lindhout T, Hemker HC: In situ-generated thrombin is the only enzyme that effectively activates factor VIII and factor V in thromboplastic-activated plasma. Blood 74:1021, 1989
12. Butenas S, van 't Veer C, Mann KG: Evaluation of the initiation phase of blood coagulation using ultrasensitive assays for serine proteases. J Biol Chem 272:21527, 1997
13. Bauer KA, Rosenberg RD: Role of antithrombin III as a regulator of in vivo coagulation. Semin Hematol 28:10, 1991
14. Bauer KA, Rosenberg RD: Control of coagulation reactions, in Beutler E, Lichtman MA, Coller BS, Kipps TJ (eds): Williams Hematology. New York, NY, McGraw-Hill, 1995, p 1239
15. Broze GJ, Warren LA, Novotny WF, Higuchi DA, Girard JJ, Miletich JP: The lipoprotein associated coagulation inhibitor that inhibits the factor VII-tissue factor complex also inhibits factor Xa: Insight into its possible mechanism of action. Blood 71:335, 1988
16. Broze GJ Jr, Girard TJ, Novotny WF: Regulation of coagulation by a multivalent Kunitz-type inhibitor. Biochem 29:7539, 1990
17. Esmon CT: The roles of protein C and thrombomodulin in the regulation of blood coagulation. J Biol Chem 264:4743, 1989
18. Rapaport SI: Inhibition of factor VIIa/tissue factor-induced blood coagulation, with particular emphasis upon a factor Xa-dependent inhibitory mechanism. Blood 73:359, 1989
19. Lawson JH, Butenas S, Ribarik N, Mann KG: Complex-dependent inhibition of factor VIIa by antithrombin III and heparin. J Biol Chem 268:767, 1993
20. Broze GJ Jr: Tissue factor pathway inhibitor and the revised theory of coagulation. Annu Rev Med 46:103, 1995
21. van't Veer C, Mann KG: Regulation of tissue factor initiated thrombin generation by the stoichiometric inhibitors tissue factor pathway inhibitor, antithrombin-III, and heparin cofactor-II. J Biol Chem 272:4367, 1997
22. Biggs R, Nossel HL: Tissue extract and the contact reaction in blood coagulation. Thromb Diath Haemorrh 6:1, 1961
23. Kitchens CS: Factor XI: A review of its biochemistry and deficiency. Semin Thromb Hemost 13:86, 1991
24. Walsh PN: Factor XI: A renaissance. Semin Hematol 29:189, 1992
25. Bolton-Maggs PHB: Factor XI deficiency. Clin Hematol 9:355, 1996
26. DeLa Cadena R, Wachtfogel YT, Colman RW: Contact activation pathway: Inflammation and coagulation, in Colman RW, Hirsh J, Marder VJ, Salzman EW (eds): Hemostasis and Thrombosis Basic Principles and Clinical Practice. San Diego, CA, Lippincott, 1994, p 219
27. Davie EW, Ratnoff OD: Waterfall sequence for intrinsic blood clotting. Science 145:1310, 1964
28. MacFarlane RG: An enzyme cascade in the blood clotting mechanism, and its function as a biochemical amplifier. Nature 202:498, 1964
29. Naito K, Fujikawa K: Activation of human blood coagulation factor XI independent of factor XII. J Biol Chem 266:7353, 1991
30. Gailani D, Broze GJ Jr: Factor XI activation in a revised model of blood coagulation. Science 253:909, 1991
31. Brunnee T, LaPorta C, Reddigari SR, Salerno VM, Kaplan AP, Silverberg M: Activation of factor XI in plasma is dependent on factor XII. Blood 81:580, 1993
32. von dem Borne PAK, Koppelman SJ, Bouma BN, Meijers JCM: Surface independent factor XI activation by thrombin in the presence of high molecular weight kininogen. Thromb Haemost 72:397, 1994
33. von dem Borne PAK, Meijers JCM, Bouma BN: Feedback activation of factor XI by thrombin in plasma results in additional thrombin that protects fibrin clots from fibrinolysis. Blood 86:3035, 1995
34. Rand MD, Lock JB, van't Veer C, Gaffney DP, Mann KG: Blood clotting in minimally altered whole blood. Blood 88:3432, 1996
35. Kettner C, Shaw E: D-Phe-Pro-ArgCh2Cl-A selective affinity label for thrombin. Thromb Res 14:969, 1979
36. R506Q J Biol Chem 270:4053, 1995
37. Kalafatis M, Haley PE, Lu D, Bertina RM, Long GL, Mann KG: Proteolytic events that regulate factor V activity in whole plasma from normal and activated protein C (APC)-resistant individuals during clotting: An insight into the APC-resistance assay. Blood 87:4695, 1996
38. Church WR, Messier T, Howard PR, Amiral J, Meyer D, Mann KG: A conserved epitope on several human vitamin K-dependent proteins. Location of the antigenic site and influence of metal ions on antibody binding. J Biol Chem 263:6259, 1988
39. Foster WB, Tucker MM, Katzmann JA, Miller RS, Mann KG: Monoclonal antibodies to human coagulation factor V and factor Va. Blood 61:1060, 1983
40. Hojima Y, Pierce JV, Pisano J: Hageman factor fragment inhibitor in corn seeds: Purification and charaterization. Thromb Res 20:149, 1980
41. Barenholz Y, Gibbes D, Litman BJ, Goll J, Thompson TE, Carlson FD: A simple method for the preparation of homogeneous phospholipid vesicles. Biochemistry 16:2806, 1997
42. Butenas S, Orfeo T, Lawson JH, Mann KG: Aminonaphthalene-sulfonamides, a new class of modifiable fluorescent detecting groups and their use in substrates for serine protease enzymes. Biochemistry 31:5399, 1992
43. Bolton-Maggs PHB, Wensley RT, Kernoff PB A, Winkelman L, Lane RS, Smith JK: Production and therapeutic use of a factor XI concentrate from plasma. Thromb Haemost 67:314, 1992
44. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680, 1970
45. Towbin H, Staehelin T, Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76:4350, 1979
46. Gallagher S, Winston SE, Fuller SA, Hurrell JGR: Analysis of proteins: Immunoblotting and immunodetection in Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K (eds): Current Protocols in Molecular Biology. New York, NY, Wiley, 1993, p 10.8.1
47. Stenner DD, Tracy RP, Riggs BL, Mann KG: Human platelets contain and secrete osteonectin, a major protein of mineralized bone. Proc Nat Acad Sci USA 83:6892, 1986
48. Keim RJ Jr, Mann KG: Human platelet osteonectin: Release, surface expression and partial characterization. Blood 75:1105, 1990
49. van 't Veer C, Golden NJ, Kalafatis M, Mann KG: Inhibitory mechanism of the protein C pathway on tissue factor-induced thrombin generation. J Biol Chem 272:7983, 1997
50. Huffman M, Monroe DM, Oliver JA, Roberts HR: Factors IXa and Xa play distinct roles in tissue factor-dependent initiation of coagulation. Blood 86:1794, 1995
51. Marciniak E: Factor-Xa inactivation by antithrombin III: Evidence for biological stabilization of factor Xa by factor V-phospholipid complex. Br J Haematol 24:391, 1973
52. Mast AE, Broze GJ: Physiological concentrations of tissue factor pathway inhibitor do not inhibit prothrombinase. Blood 87:1845, 1996
53. Hovig T, Dodds WJ, Rowsell HC, Mustard JF: The transformation of haemostatic platelet plugs in normal and factor IX deficient dogs. Am J Pathol 53:355, 1968
54. Sixma JJ, van den Berg A: The haemostatic plug in haemophilia A: A morphological study of haemostatic plug formation in bleeding time skin wounds of patients with severe haemophilia A. Br J Haematol 58:741, 1984
55. McDonagh J: Structure and function of factor XIII, in Colman RW, Hirsh J, Marder VJ, Salzman EW (eds): Hemostasis and Thrombosis: Basic Principles and Clinical Practice. Philadelphia, PA, Lippincott, 1994, p 301
56. Walsh PN, Rizza CR, Matthews JM, Eipe J, Kernoff PBA, Coles MD, Bloom AL, Kaufman BM, Beck P, Hanan CM, Biggs R: Epsilon-aminocaproic acid therapy for dental extractions in haemophilia and Christmas disease: A double blind controlled trial. Br J Haematol 20:463, 1997
57. Bajzar L, Manuel R, Nesheim ME: Purification and characterization of TAFI, a thrombin-activable fibrinolysis inhibitor. J Biol Chem 270:14477, 1995
58. Broze GJ Jr, Higuchi D: Coagulation-dependent inhibition of fibrinolysis: Role of carboxypeptidase-U and the premature lysis of clots from hemophilic plasma. Blood 88:3815, 1996
59. Nesheim ME, Wang W, Boffa M, Nagashima M, Morser J, Bajzar L: Thrombin, thrombomodulin and TAFI in the molecular link between coagulation and fibrinolysis. Thromb Haemost 78:386, 199
60. Minnema MC. Friederich PW, Levi M, Meijers JCM, Biemond BJ, Bouma BN, ten Cate H: Inhibition of factor XI activity results in enhanced endogenous thrombolysis in a rabbit thrombosis model. Thromb Haemost 77:215, 1997 (abstr, suppl)
61. von dem Borne PAK, Meijers JCM, Seligsohn U, Bouma BN: Variable potential of the intrinsic coagulation pathway for inhibition of plasma clot lysis in normal and factor XI deficient individuals. Thromb Haemost 77:212, 1997 (abstr, suppl)